Journal
CLINICAL INFECTIOUS DISEASES
Volume 73, Issue 9, Pages E3098-E3101Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa1890
Keywords
community-based SARS-CoV-2 testing; asymptomatic SARS-CoV-2 infection
Categories
Funding
- University of California San Francisco, Program for Breakthrough Biomedical Research - Sandler Foundation
- Chan Zuckerberg Initiative
- National Institutes of Health [UM1AI069496]
Ask authors/readers for more resources
The study conducted testing for SARS-CoV-2 among 3302 individuals in a community setting using BinaxNOW(TM) and reverse transcription polymerase chain reaction (RT-PCR). The rapid assay showed high sensitivity and specificity, with consistent performance across different age groups and symptomatic status, allowing for immediate public health action.
Among 3302 persons tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by BinaxNOW (TM) and reverse transcription polymerase chain reaction (RT-PCR) in a community setting, rapid assay sensitivity was 100%/98.5%/89% using RT-PCR cycle thresholds of 30, 35, and no threshold. The specificity was 99.9%. Performance was high across ages and those with and without symptoms. Rapid resulting permitted immediate public health action.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available